BCR and diffuse large B-cell lymphoma: We thus explored the effects of metformin on the BCR signaling and cholesterol synthesis in DLBCL cell lines first, and then compared the outcomes of diabetic DLBCL patients on metformin with those on other hypoglycemic agents.